Search research articles
Contact Us
Filters
Showing results (41-50 of 362) with videos related to
Page
of 37
Sort By:
The EMBO Journal
|
December 1, 1990
Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers
E L Zechiedrich, N Osheroff
The Journal of Biological Chemistry
|
July 4, 1998
Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage
J M Fortune, N Osheroff
Current Pharmaceutical Design
|
March 20, 2001
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde
V E Anderson, N Osheroff
The Journal of Biological Chemistry
|
March 14, 1997
Spontaneous DNA damage stimulates topoisomerase II-mediated DNA cleavage
P S Kingma, N Osheroff
Biochimica Et Biophysica Acta
|
September 28, 1998
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
D A Burden, N Osheroff
Mutation Research
|
August 8, 2007
DNA topoisomerase II, genotoxicity, and cancer
A Kathleen McClendon, Neil Osheroff
Methods in Molecular Biology (Clifton, N.J.)
|
May 15, 2025
DNA Cleavage Mediated by Bacterial Type II Topoisomerases
Chelsea A Mann, Neil Osheroff
International Journal of Molecular Sciences
|
September 9, 2023
No Time to Relax and Unwind: Exploration of Topoisomerases and a Growing Field of Study
Joseph E Deweese, Neil Osheroff
Methods in Molecular Biology (Clifton, N.J.)
|
July 8, 2003
Introduction to DNA topoisomerases
M A Bjornsti, N Osheroff
Metallomics : Integrated Biometal Science
|
August 13, 2010
The use of divalent metal ions by type II topoisomerases
Joseph E Deweese, Neil Osheroff
Page
of 37
Search research articles
Search
Showing results (41-50 of 362) with videos related to
Sort By:
Page
of 37
The EMBO Journal
|
December 1, 1990
Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers
E L Zechiedrich, N Osheroff
The Journal of Biological Chemistry
|
July 4, 1998
Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage
J M Fortune, N Osheroff
Current Pharmaceutical Design
|
March 20, 2001
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde
V E Anderson, N Osheroff
The Journal of Biological Chemistry
|
March 14, 1997
Spontaneous DNA damage stimulates topoisomerase II-mediated DNA cleavage
P S Kingma, N Osheroff
Biochimica Et Biophysica Acta
|
September 28, 1998
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
D A Burden, N Osheroff
Mutation Research
|
August 8, 2007
DNA topoisomerase II, genotoxicity, and cancer
A Kathleen McClendon, Neil Osheroff
Methods in Molecular Biology (Clifton, N.J.)
|
May 15, 2025
DNA Cleavage Mediated by Bacterial Type II Topoisomerases
Chelsea A Mann, Neil Osheroff
International Journal of Molecular Sciences
|
September 9, 2023
No Time to Relax and Unwind: Exploration of Topoisomerases and a Growing Field of Study
Joseph E Deweese, Neil Osheroff
Methods in Molecular Biology (Clifton, N.J.)
|
July 8, 2003
Introduction to DNA topoisomerases
M A Bjornsti, N Osheroff
Metallomics : Integrated Biometal Science
|
August 13, 2010
The use of divalent metal ions by type II topoisomerases
Joseph E Deweese, Neil Osheroff
Page
of 37